We distribute misoprostol and train providers to provide life-saving abortion-related care with it, including treatment of incomplete abortion.
As a key component of safe abortion and post-abortion care, misoprostol is a World Health Organization-recommended method to treat incomplete abortion and manage early miscarriage (spontaneous abortion). Incomplete and spontaneous abortions require immediate treatment to avoid potentially fatal infections or permanent disability.
Misoprostol can be used to safely treat an uncomplicated incomplete abortion, which is the case for most incomplete abortions. Misoprostol is ideal for low-resource settings because it is inexpensive, heat and light-stable, does not need to be refrigerated and can be given in tablet form. Compared to surgical completion of abortion, misoprostol does not require anesthesia or surgery, has low risk for infection, and does not require advanced training for health providers.
PSI supports or implements programs that use misoprostol for post-abortion care (PAC) and safe abortion in nearly 20 countries in Africa, Asia and Latin America. As part of its safe abortion and PAC interventions, PSI:
- Trains healthcare providers and pharmacy staff in PAC countries on the correct use of misoprostol as well as referring women with complications to higher-level facilities when necessary.
- Supports countries to register misoprostol products and make them available to women through a variety of channels, including both public and private health centers and pharmacies.
- Educates women on safe abortion, the legality of PAC and where to access safe abortion and PAC services through interpersonal communication agents and other communications activities.
- Reproductive Health Supplies Coalition: Plenary Session Presentation
On October 13, FPwatch findings from Ethiopia were presented at the Reproductive Health Supplies Coalition (RHSC) Annual Meeting in Seattle.